Express Pharma

JANUARY 25, 2025

The Indian pharmaceutical sector is loaded with talent and has made great strides in generic medicine development. However, massive R&D expenditure is necessary to drive the next generation of discoveries. A strong pharmaceutical ecosystem relies heavily on research and development (R&D).

Generic Medicine 76

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 76

Express Pharma

APRIL 7, 2025

This strategy has been particularly prominent in countries like India, which is one of the largest producers of generic medicines and has been a key player in the global FDC market.

Diabetes 66

Diabetes Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 66

pharmaphorum

JANUARY 24, 2023

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee.

Generic Medicine 59

Generic Medicine 59

Express Pharma

APRIL 11, 2023

The pundits are unanimous in their response – changes in the US generic drug market. The US is the biggest market for generic medicines (~90 per cent of prescriptions are fulfilled by generic drugs). What is the reason behind this lull as far as the Indian life science companies are concerned?

Drug Development 98

Drug Development Generic Medicine Documentation 98

Express Pharma

SEPTEMBER 6, 2023

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

Quality Matters

SEPTEMBER 15, 2023

See also the related Quality Matters blog on industry take-aways from the workshop.] [Editor’s note: The following is a snapshot of workshop take-aways focused on the PCM regulatory landscape. It is not intended as a comprehensive summary or report.

Generic Medicine 52

Generic Medicine Pharmaceutical Manufacturing Communication 52

Express Pharma

NOVEMBER 15, 2024

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Packaging 102

Packaging Generic Medicine Pharmaceutical Manufacturing Vaccines 102